{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T20:41:34Z","timestamp":1770669694325,"version":"3.49.0"},"reference-count":77,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T00:00:00Z","timestamp":1721001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100002721","name":"Charcot\u2013Marie\u2013Tooth Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002721","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"NINDS","doi-asserted-by":"publisher","award":["5R01NS105755"],"award-info":[{"award-number":["5R01NS105755"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>DNA-based therapeutics have emerged as a revolutionary approach for addressing the treatment gap in rare inherited conditions by targeting the fundamental genetic causes of disease. Charcot\u2013Marie\u2013Tooth (CMT) disease, a group of inherited neuropathies, represents one of the most prevalent Mendelian disease groups in neurology and is characterized by diverse genetic aetiology. Axonal forms of CMT, known as CMT2, are caused by dominant mutations in &amp;gt;30 different genes that lead to degeneration of lower motor neuron axons. Recent advances in antisense oligonucleotide therapeutics have shown promise in targeting neurodegenerative disorders.<\/jats:p>\n               <jats:p>Here, we elucidate pathomechanistic changes contributing to variant specific molecular phenotypes in CMT2E, caused by a single nucleotide substitution (p.N98S) in the neurofilament light chain gene (NEFL). We used a patient-derived induced pluripotent stem cell-induced motor neuron model that recapitulates several cellular and biomarker phenotypes associated with CMT2E. Using an antisense oligonucleotide treatment strategy targeting a heterozygous gain-of-function variant, we aimed to resolve molecular phenotypic changes observed in the CMT2E p.N98S subtype. To determine the therapeutic potential of antisense oligonucleotide, we applied our treatment strategy in induced pluripotent stem cell-derived motor neurons and used both established and new biomarkers of peripheral nervous system axonal degeneration.<\/jats:p>\n               <jats:p>Our findings demonstrated a significant decrease in clinically relevant biomarkers of axonal degeneration, presenting the first clinically viable genetic therapeutic for CMT2E. Similar strategies could be used to develop precision medicine approaches for otherwise untreatable gain-of-function inherited disorders.<\/jats:p>","DOI":"10.1093\/brain\/awae225","type":"journal-article","created":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T18:15:39Z","timestamp":1721067339000},"page":"4227-4239","source":"Crossref","is-referenced-by-count":5,"title":["Customized antisense oligonucleotide-based therapy for neurofilament-associated Charcot\u2013Marie\u2013Tooth disease"],"prefix":"10.1093","volume":"147","author":[{"given":"Jessica","family":"Medina","sequence":"first","affiliation":[{"name":"Dr. John T. Macdonald Foundation Department of Human Genetics, University of Miami Miller School of Medicine , Miami, FL 33136 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5669-7415","authenticated-orcid":false,"given":"Adriana","family":"Rebelo","sequence":"additional","affiliation":[{"name":"Dr. John T. Macdonald Foundation Department of Human Genetics, University of Miami Miller School of Medicine , Miami, FL 33136 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matt C","family":"Danzi","sequence":"additional","affiliation":[{"name":"Dr. John T. Macdonald Foundation Department of Human Genetics, University of Miami Miller School of Medicine , Miami, FL 33136 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth H","family":"Jacobs","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Miami Miller School of Medicine , Miami, FL 33136 ,","place":["USA"]},{"name":"Medical Scientist Training Program, University of Miami Miller School of Medicine , Miami, FL 33136 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isaac R L","family":"Xu","sequence":"additional","affiliation":[{"name":"Dr. John T. Macdonald Foundation Department of Human Genetics, University of Miami Miller School of Medicine , Miami, FL 33136 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen P","family":"Ahrens","sequence":"additional","affiliation":[{"name":"Dr. John T. Macdonald Foundation Department of Human Genetics, University of Miami Miller School of Medicine , Miami, FL 33136 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sitong","family":"Chen","sequence":"additional","affiliation":[{"name":"Dr. John T. Macdonald Foundation Department of Human Genetics, University of Miami Miller School of Medicine , Miami, FL 33136 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacquelyn","family":"Raposo","sequence":"additional","affiliation":[{"name":"Dr. John T. Macdonald Foundation Department of Human Genetics, University of Miami Miller School of Medicine , Miami, FL 33136 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Yanick","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Miami Miller School of Medicine , Miami, FL 33136 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8498-5235","authenticated-orcid":false,"given":"Stephan","family":"Zuchner","sequence":"additional","affiliation":[{"name":"Dr. John T. Macdonald Foundation Department of Human Genetics, University of Miami Miller School of Medicine , Miami, FL 33136 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario A","family":"Saporta","sequence":"additional","affiliation":[{"name":"Department of Neurology, University of Miami Miller School of Medicine , Miami, FL 33136 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,7,15]]},"reference":[{"key":"2024121223583048100_awae225-B1","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1399-0004.1974.tb00638.x","article-title":"Genetic and clinical aspects of Charcot-Marie-Tooth\u2019s disease","volume":"6","author":"Skre","year":"1974","journal-title":"Clin Genet"},{"key":"2024121223583048100_awae225-B2","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/jnnp.62.4.310","article-title":"Epidemiology of peripheral neuropathy","volume":"62","author":"Martyn","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2024121223583048100_awae225-B3","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/WCO.0000000000000735","article-title":"Charcot\u2013Marie\u2013Tooth disease and related disorders","volume":"32","author":"Laur\u00e1","year":"2019","journal-title":"Curr Opin Neurol"},{"key":"2024121223583048100_awae225-B4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3390\/genes5010013","article-title":"Genetics of Charcot-Marie-Tooth (CMT) disease within the frame of the human genome project success","volume":"5","author":"Timmerman","year":"2014","journal-title":"Genes (Basel)"},{"key":"2024121223583048100_awae225-B5","first-page":"91","article-title":"Hereditary neuropathies","volume":"115","author":"Eggermann","year":"2018","journal-title":"Dtsch Aerzteblatt Int"},{"key":"2024121223583048100_awae225-B6","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1136\/jnnp-2014-308826","article-title":"CMT subtypes and disease burden in patients enrolled in the Inherited Neuropathies Consortium natural history study: A cross-sectional analysis","volume":"86","author":"Fridman","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2024121223583048100_awae225-B7","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/ana.22166","article-title":"Charcot-marie-tooth disease subtypes and genetic testing strategies","volume":"69","author":"Saporta","year":"2011","journal-title":"Ann Neurol"},{"key":"2024121223583048100_awae225-B8","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1136\/jnnp-2016-315077","article-title":"Genetic and clinical characteristics of NEFL-related Charcot-Marie-Tooth disease","volume":"88","author":"Horga","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2024121223583048100_awae225-B9","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/cm.21676","article-title":"A review and analysis of the clinical literature on Charcot\u2013Marie\u2013Tooth disease caused by mutations in neurofilament protein L","volume":"78","author":"Stone","year":"2021","journal-title":"Cytoskeleton"},{"key":"2024121223583048100_awae225-B10","doi-asserted-by":"crossref","first-page":"146532","DOI":"10.1016\/j.brainres.2019.146532","article-title":"Overlapping spectrums: The clinicogenetic commonalities between Charcot-Marie-Tooth and other neurodegenerative diseases","volume":"1727","author":"Martin","year":"2020","journal-title":"Brain Res"},{"key":"2024121223583048100_awae225-B11","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/ana.21728","article-title":"A novel recessive Nefl mutation causes a severe, early-onset axonal neuropathy","volume":"66","author":"Yum","year":"2009","journal-title":"Ann Neurol"},{"key":"2024121223583048100_awae225-B12","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/jnr.20493","article-title":"Mice with the deleted neurofilament of low molecular weight (Nefl) gene: 2. Effects on motor functions and spatial orientation","volume":"80","author":"Dubois","year":"2005","journal-title":"J Neurosci Res"},{"key":"2024121223583048100_awae225-B13","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jns.2016.04.007","article-title":"N98S mutation in NEFL gene is dominantly inherited with a phenotype of polyneuropathy and cerebellar atrophy","volume":"365","author":"Yang","year":"2016","journal-title":"J Neurol Sci"},{"key":"2024121223583048100_awae225-B14","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1093\/hmg\/ddu736","article-title":"Neurofilament light polypeptide gene N98S mutation in mice leads to neurofilament network abnormalities and a Charcot-Marie-Tooth type 2E phenotype","volume":"24","author":"Adebola","year":"2015","journal-title":"Hum Mol Genet"},{"key":"2024121223583048100_awae225-B15","doi-asserted-by":"crossref","first-page":"e0180038","DOI":"10.1371\/journal.pone.0180038","article-title":"Abnormal neurofilament inclusions and segregations in dorsal root ganglia of a Charcot-Marie-Tooth type 2E mouse model","volume":"12","author":"Zhao","year":"2017","journal-title":"PLoS One"},{"key":"2024121223583048100_awae225-B16","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.expneurol.2014.10.005","article-title":"Axonal Charcot-Marie-Tooth disease patient-derived motor neurons demonstrate disease-specific phenotypes including abnormal electrophysiological properties","volume":"263","author":"Saporta","year":"2015","journal-title":"Exp Neurol"},{"key":"2024121223583048100_awae225-B17","first-page":"76","article-title":"Review: The synthesis, axonal transport, and phosphorylation of neurofilaments determine axonal caliber in myelinated nerve fibers","volume":"1","author":"Hoffman","year":"1995","journal-title":"Neurosci"},{"key":"2024121223583048100_awae225-B18","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/neu.10270","article-title":"Functions of intermediate filaments in neuronal development and disease","volume":"58","author":"Lariviere","year":"2004","journal-title":"J Neurobiol"},{"key":"2024121223583048100_awae225-B19","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.1073\/pnas.75.10.5034","article-title":"Different intermediate-sized filaments distinguished by immunofluorescence microscopy","volume":"75","author":"Franke","year":"1978","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024121223583048100_awae225-B20","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1242\/jcs.104729","article-title":"Neurofilaments at a glance","volume":"125","author":"Yuan","year":"2012","journal-title":"J Cell Sci"},{"key":"2024121223583048100_awae225-B21","doi-asserted-by":"crossref","first-page":"ar68","DOI":"10.1091\/mbc.E23-01-0024","article-title":"Regulation of neurofilament length and transport by a dynamic cycle of phospho-dependent polymer severing and annealing","volume":"34","author":"Uchida","year":"2023","journal-title":"Mol Biol Cell"},{"key":"2024121223583048100_awae225-B22","doi-asserted-by":"crossref","first-page":"E2696","DOI":"10.1073\/pnas.1221835110","article-title":"Severing and end-to-end annealing of neurofilaments in neurons","volume":"110","author":"Uchida","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2024121223583048100_awae225-B23","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ejcb.2008.11.004","article-title":"Neurofilament subunit (NFL) head domain phosphorylation regulates axonal transport of neurofilaments","volume":"88","author":"Yates","year":"2009","journal-title":"Eur J Cell Biol"},{"key":"2024121223583048100_awae225-B24","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1083\/jcb.123.6.1517","article-title":"The rod domain of NF-L determines neurofilament architecture, whereas the end domains specify filament assembly and network formation","volume":"123","author":"Heins","year":"1993","journal-title":"J Cell Biol"},{"key":"2024121223583048100_awae225-B25","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1046\/j.1471-4159.1996.66031207.x","article-title":"Activation of cyclic AMP-dependent protein kinase in okadaic acid-treated neurons potentiates neurofilament fragmentation and stimulates phosphorylation of Ser2 in the low-molecular-mass neurofilament subunit","volume":"66","author":"Giasson","year":"2002","journal-title":"J Neurochem"},{"key":"2024121223583048100_awae225-B26","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1021\/bi030196q","article-title":"Identification of endogenous phosphorylation sites of bovine medium and low molecular weight neurofilament proteins by tandem mass spectrometry","volume":"43","author":"Trimpin","year":"2004","journal-title":"Biochemistry"},{"key":"2024121223583048100_awae225-B27","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1046\/j.1471-4159.2000.0740949.x","article-title":"Major phosphorylation site (Ser55) of neurofilament L by cyclic AMP-dependent protein kinase in rat primary neuronal culture","volume":"74","author":"Nakamura","year":"2000","journal-title":"J Neurochem"},{"key":"2024121223583048100_awae225-B28","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.1021\/bi9724523","article-title":"Identification of novel in vitro PKA phosphorylation sites on the low and middle molecular mass neurofilament subunits by mass spectrometry","volume":"37","author":"Cleverley","year":"1998","journal-title":"Biochemistry"},{"key":"2024121223583048100_awae225-B29","doi-asserted-by":"crossref","first-page":"18861","DOI":"10.1016\/S0021-9258(18)55143-7","article-title":"Identification of Ser-55 as a major protein kinase A phosphorylation site on the 70-kDa subunit of neurofilaments. Early turnover during axonal transport","volume":"266","author":"Sihag","year":"1991","journal-title":"J Biol Chem"},{"key":"2024121223583048100_awae225-B30","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1046\/j.1471-4159.1999.0720491.x","article-title":"Serine-23 is a major protein kinase A phosphorylation site on the amino-terminal head domain of the middle molecular mass subunit of neurofilament proteins","volume":"72","author":"Sihag","year":"1999","journal-title":"J Neurochem"},{"key":"2024121223583048100_awae225-B31","doi-asserted-by":"crossref","first-page":"16298","DOI":"10.1016\/S0021-9258(18)66564-0","article-title":"Differential turnover of phosphate groups on neurofilament subunits in mammalian neurons in vivo","volume":"261","author":"Nixon","year":"1986","journal-title":"J Biol Chem"},{"key":"2024121223583048100_awae225-B32","doi-asserted-by":"crossref","first-page":"6558","DOI":"10.1038\/s41467-023-42227-0","article-title":"O-GlcNAcylation regulates neurofilament-light assembly and function and is perturbed by Charcot-Marie-Tooth disease mutations","volume":"14","author":"Huynh","year":"2023","journal-title":"Nat Commun"},{"key":"2024121223583048100_awae225-B33","doi-asserted-by":"crossref","first-page":"643681","DOI":"10.3389\/fmolb.2021.643681","article-title":"Nucleic acid-based therapeutics in orphan neurological disorders: Recent developments","volume":"8","author":"Khorkova","year":"2021","journal-title":"Front Mol Biosci"},{"key":"2024121223583048100_awae225-B34","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1038\/mt.2014.153","article-title":"In vivo evaluation of candidate allele-specific mutant huntingtin gene silencing antisense oligonucleotides","volume":"22","author":"Southwell","year":"2014","journal-title":"Mol Ther"},{"key":"2024121223583048100_awae225-B35","doi-asserted-by":"crossref","first-page":"e107434","DOI":"10.1371\/journal.pone.0107434","article-title":"Allele-specific suppression of mutant huntingtin using antisense oligonucleotides: Providing a therapeutic option for all huntington disease patients","volume":"9","author":"Skotte","year":"2014","journal-title":"PLoS One"},{"key":"2024121223583048100_awae225-B36","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/978-1-4939-8651-4_26","article-title":"Pre-mRNA splicing modulation by antisense oligonucleotides","volume":"1828","author":"Singh","year":"2018","journal-title":"Methods Mol Biol"},{"key":"2024121223583048100_awae225-B37","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1007\/s13311-022-01247-2","article-title":"Antisense oligonucleotides for the study and treatment of ALS","volume":"19","author":"Boros","year":"2022","journal-title":"Neurotherapeutics"},{"key":"2024121223583048100_awae225-B38","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41591-021-01615-z","article-title":"Antisense oligonucleotide silencing of FUS expression as a therapeutic approach in amyotrophic lateral sclerosis","volume":"28","author":"Korobeynikov","year":"2022","journal-title":"Nat Med"},{"key":"2024121223583048100_awae225-B39","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.omtn.2023.01.006","article-title":"Sustained therapeutic benefits by transient reduction of TDP-43 using ENA-modified antisense oligonucleotides in ALS\/FTD mice","volume":"31","author":"Takeuchi","year":"2023","journal-title":"Mol Ther Nucleic Acids"},{"key":"2024121223583048100_awae225-B40","doi-asserted-by":"crossref","first-page":"3558","DOI":"10.1172\/JCI99081","article-title":"Antisense oligonucleotides extend survival and reverse decrement in muscle response in ALS models","volume":"128","author":"McCampbell","year":"2018","journal-title":"J Clin Invest"},{"key":"2024121223583048100_awae225-B41","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S1474-4422(22)00121-1","article-title":"Potential disease-modifying therapies for Huntington\u2019s disease: Lessons learned and future opportunities","volume":"21","author":"Tabrizi","year":"2022","journal-title":"Lancet Neurol"},{"key":"2024121223583048100_awae225-B42","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1016\/j.ymthe.2021.04.008","article-title":"Gene therapy for ALS: A review","volume":"29","author":"Amado","year":"2021","journal-title":"Mol Ther"},{"key":"2024121223583048100_awae225-B43","doi-asserted-by":"crossref","first-page":"4562","DOI":"10.1093\/brain\/awad234","article-title":"Peripherin is a biomarker of axonal damage in peripheral nervous system disease","volume":"146","author":"Keddie","year":"2023","journal-title":"Brain"},{"key":"2024121223583048100_awae225-B44","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1002\/acn3.51419","article-title":"Evaluation of peripherin in biofluids of patients with motor neuron diseases","volume":"8","author":"Sabbatini","year":"2021","journal-title":"Ann Clin Transl Neurol"},{"key":"2024121223583048100_awae225-B45","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.4155\/bio-2019-0163","article-title":"Establishment of neurofilament light chain Simoa assay in cerebrospinal fluid and blood","volume":"11","author":"Hendricks","year":"2019","journal-title":"Bioanalysis"},{"key":"2024121223583048100_awae225-B46","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/WCO.0000000000001168","article-title":"Presymptomatic amyotrophic lateral sclerosis: From characterization to prevention","volume":"36","author":"Benatar","year":"2023","journal-title":"Curr Opin Neurol"},{"key":"2024121223583048100_awae225-B47","doi-asserted-by":"crossref","first-page":"689938","DOI":"10.3389\/fnins.2021.689938","article-title":"Neurofilament proteins as biomarkers to monitor neurological diseases and the efficacy of therapies","volume":"15","author":"Yuan","year":"2021","journal-title":"Front Neurosci"},{"key":"2024121223583048100_awae225-B48","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1002\/cpt.1718","article-title":"Human tridimensional neuronal cultures for phenotypic drug screening in inherited peripheral neuropathies","volume":"107","author":"Maciel","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"2024121223583048100_awae225-B49","doi-asserted-by":"crossref","first-page":"14114","DOI":"10.1038\/s41598-017-14179-1","article-title":"Neurofilament light protein in CSF and blood is associated with neurodegeneration and disease severity in Huntington\u2019s disease R6\/2 mice","volume":"7","author":"Soylu-Kucharz","year":"2017","journal-title":"Sci Rep"},{"key":"2024121223583048100_awae225-B50","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.nbd.2017.04.007","article-title":"NF-L in cerebrospinal fluid and serum is a biomarker of neuronal damage in an inducible mouse model of neurodegeneration","volume":"104","author":"Brureau","year":"2017","journal-title":"Neurobiol Dis"},{"key":"2024121223583048100_awae225-B51","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/mus.28054","article-title":"Multifocal motor neuropathy as a mimic of amyotrophic lateral sclerosis: Serum neurofilament light chain as a reliable diagnostic biomarker","volume":"69","author":"Kleinveld","year":"2024","journal-title":"Muscle Nerve"},{"key":"2024121223583048100_awae225-B52","doi-asserted-by":"crossref","first-page":"e252","DOI":"10.1212\/WNL.0000000000007767","article-title":"Plasma and CSF neurofilament light: Relation to longitudinal neuroimaging and cognitive measures","volume":"93","author":"Mielke","year":"2019","journal-title":"Neurology"},{"key":"2024121223583048100_awae225-B53","first-page":"1308","article-title":"Neurofilament light chain as a biomarker for diagnosis of multiple sclerosis","volume":"20","author":"Kouchaki","year":"2021","journal-title":"EXCLI J"},{"key":"2024121223583048100_awae225-B54","doi-asserted-by":"crossref","first-page":"15416","DOI":"10.3390\/ijms232315416","article-title":"Role of the intermediate filament protein peripherin in health and disease","volume":"23","author":"Romano","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2024121223583048100_awae225-B55","doi-asserted-by":"crossref","first-page":"7614","DOI":"10.3390\/ijms22147614","article-title":"PLEKHA8P1 promotes tumor progression and indicates poor prognosis of liver cancer","volume":"22","author":"Lee","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2024121223583048100_awae225-B56","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1242\/jcs.105817","article-title":"14-3-3 proteins interact with neurofilament protein-L (NF-L) and regulate dynamic assembly of neurofilaments","volume":"126","author":"Miao","year":"2012","journal-title":"J Cell Sci"},{"key":"2024121223583048100_awae225-B57","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13024-019-0318-4","article-title":"The role of neurofilament aggregation in neurodegeneration: Lessons from rare inherited neurological disorders","volume":"14","author":"Didonna","year":"2019","journal-title":"Mol Neurodegener"},{"key":"2024121223583048100_awae225-B58","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1716793","article-title":"Inotersen treatment for patients with hereditary transthyretin amyloidosis","volume":"379","author":"Benson","year":"2018","journal-title":"N Engl J Med"},{"key":"2024121223583048100_awae225-B59","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1016\/S0140-6736(16)31408-8","article-title":"Treatment of infantile-onset spinal muscular atrophy with nusinersen: A phase 2, open-label, dose-escalation study","volume":"388","author":"Finkel","year":"2016","journal-title":"Lancet"},{"key":"2024121223583048100_awae225-B60","doi-asserted-by":"crossref","first-page":"100416","DOI":"10.1016\/j.jbc.2021.100416","article-title":"Antisense technology: A review","volume":"296","author":"Crooke","year":"2021","journal-title":"J Biol Chem"},{"key":"2024121223583048100_awae225-B61","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.1523\/JNEUROSCI.5299-06.2007","article-title":"Conditional NF-L transgene expression in mice for in vivo analysis of turnover and transport rate of neurofilaments","volume":"27","author":"Millecamps","year":"2007","journal-title":"J Neurosci"},{"key":"2024121223583048100_awae225-B62","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1083\/jcb.102.2.647","article-title":"Multiple fates of newly synthesized neurofilament proteins: Evidence for a stationary neurofilament network distributed nonuniformly along axons of retinal ganglion cell neurons","volume":"102","author":"Nixon","year":"1986","journal-title":"J Cell Biol"},{"key":"2024121223583048100_awae225-B63","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3389\/fnmol.2016.00072","article-title":"Gene expression analysis of neurons and astrocytes isolated by laser capture microdissection from frozen human brain tissues","volume":"9","author":"Tagliafierro","year":"2016","journal-title":"Front Mol Neurosci"},{"key":"2024121223583048100_awae225-B64","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1212\/WNL.0000000000001773","article-title":"Reduced neurofilament expression in cutaneous nerve fibers of patients with CMT2E","volume":"85","author":"Pisciotta","year":"2015","journal-title":"Neurology"},{"key":"2024121223583048100_awae225-B65","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1093\/hmg\/11.23.2837","article-title":"Charcot-Marie-Tooth disease neurofilament mutations disrupt neurofilament assembly and axonal transport","volume":"11","author":"Brownlees","year":"2002","journal-title":"Hum Mol Genet"},{"issue":"7-8","key":"2024121223583048100_awae225-B66","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/cm.21566","article-title":"Charcot\u2013Marie\u2013Tooth disease type 2E\/1F mutant neurofilament proteins assemble into neurofilaments","volume":"76","author":"Stone","year":"2019","journal-title":"Cytoskeleton"},{"key":"2024121223583048100_awae225-B67","doi-asserted-by":"crossref","first-page":"5101","DOI":"10.1074\/jbc.273.9.5101","article-title":"Neurofilament (NF) assembly; divergent characteristics of human and rodent NF-L subunits","volume":"273","author":"Carter","year":"1998","journal-title":"J Biol Chem"},{"key":"2024121223583048100_awae225-B68","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/BF02881767","article-title":"Coil-1 of rod domain of NF-L is essential for its assembly in vivo","volume":"42","author":"Tong","year":"1999","journal-title":"Sci China Ser C Life Sci"},{"key":"2024121223583048100_awae225-B69","doi-asserted-by":"crossref","first-page":"868","DOI":"10.5483\/BMBRep.2008.41.12.868","article-title":"The effect of rod domain A148V mutation of neurofilament light chain on filament formation","volume":"41","author":"Lee","year":"2008","journal-title":"BMB Rep"},{"key":"2024121223583048100_awae225-B70","doi-asserted-by":"crossref","first-page":"e244","DOI":"10.1212\/NXG.0000000000000244","article-title":"Absence of NEFL in patient-specific neurons in early-onset Charcot-Marie-Tooth neuropathy","volume":"4","author":"Sainio","year":"2018","journal-title":"Neurol Genet"},{"key":"2024121223583048100_awae225-B71","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.4103\/1673-5374.385285","article-title":"Antisense therapy: A potential breakthrough in the treatment of neurodegenerative diseases","volume":"19","author":"Romano","year":"2024","journal-title":"Neural Regen Res"},{"key":"2024121223583048100_awae225-B72","doi-asserted-by":"crossref","first-page":"1304342","DOI":"10.3389\/fphar.2023.1304342","article-title":"Antisense oligonucleotides: A novel frontier in pharmacological strategy","volume":"14","author":"Collotta","year":"2023","journal-title":"Front Pharmacol"},{"key":"2024121223583048100_awae225-B73","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1056\/NEJMoa2204705","article-title":"Trial of antisense oligonucleotide tofersen for SOD1 ALS","volume":"387","author":"Miller","year":"2022","journal-title":"N Engl J Med"},{"key":"2024121223583048100_awae225-B74","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1056\/NEJMoa1900907","article-title":"Targeting huntingtin expression in patients with Huntington\u2019s disease","volume":"380","author":"Tabrizi","year":"2019","journal-title":"N Engl J Med"},{"key":"2024121223583048100_awae225-B75","doi-asserted-by":"crossref","first-page":"723023","DOI":"10.3389\/fcell.2021.723023","article-title":"Allele-specific gene editing rescues pathology in a human model of Charcot-Marie-Tooth disease type 2E","volume":"9","author":"Feliciano","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"2024121223583048100_awae225-B76","first-page":"567","article-title":"CRISPR\/cas9 genome editing for neurodegenerative diseases","volume":"22","author":"Nouri Nojadeh","year":"2023","journal-title":"EXCLI J"},{"key":"2024121223583048100_awae225-B77","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.expneurol.2018.06.010","article-title":"Myelinated axons fail to develop properly in a genetically authentic mouse model of Charcot-Marie-Tooth disease type 2E","volume":"308","author":"Lancaster","year":"2018","journal-title":"Exp Neurol"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/brain\/advance-article-pdf\/doi\/10.1093\/brain\/awae225\/59633925\/awae225.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/brain\/article-pdf\/147\/12\/4227\/60939514\/awae225.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/brain\/article-pdf\/147\/12\/4227\/60939514\/awae225.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T23:58:57Z","timestamp":1734047937000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/article\/147\/12\/4227\/7713870"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,15]]},"references-count":77,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,7,15]]},"published-print":{"date-parts":[[2024,12,3]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awae225","relation":{},"ISSN":["0006-8950","1460-2156"],"issn-type":[{"value":"0006-8950","type":"print"},{"value":"1460-2156","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,12]]},"published":{"date-parts":[[2024,7,15]]}}}